Back

Prognostic impact of combined endothelium-dependent and endothelium-independent coronary flow reserve on cardiovascular outcomes

29 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes: intracoronary diagnosis Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kai Nogami

Mayo Clinic, Rochester (United States of America)

6 More presentations in this session

Presentation thumbnail
Comparison of FFR-angio and non-hyperemic pressure ratios in patients with aortic stenosis
Doctor R. Inaba (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
FFR-guided complete revascularization vs culprit-only primary PCI among hemodynamically stable STEMI patients with multivessel disease: a meta-analysis
Doctor J. Isanan (Cebu City, PH)
Abstract Slides Video
Presentation thumbnail
The prognostic relevance of delta fractional flow ratio and delta quantitative flow ratio in cardiovascular outcomes
Doctor B. Csanadi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Sex-stratified analysis of the Functional FFRCT Score distribution and prognostic value in the FORECAST cohort
Doctor L. Gabara (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
CCTA and FFR-CT: foes or friends in detecting significant lesions in high-risk NSTE-ACS patients?
Miss A. Zimmerli (Lausanne, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes: intracoronary diagnosis

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Session
Novel prognosticators in chronic coronary syndromes
thumbnail
Congress Presentation
A comprehensive approach combining FFR, CFR, and IMR in order to predict adverse cardiovascular events in patients with non-obstructive coronary artery disease
thumbnail
Congress Presentation
Prognostic stratification by coronary flow reserve and left atrial volume index in patients with non-obstructive coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources